HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fever without source in infants and young children: dilemma in diagnosis and management.

AbstractBACKGROUND:
There is controversy surrounding the management of young children who have a fever without a source (FWS). Several strategies have been designed with the purpose of managing children with FWS.
AIMS:
To assess the applicability of a standardized guideline for children up to 36 months of age with FWS.
SETTING:
Pediatric emergency unit, Al-Adan Hospital, Kuwait City, Kuwait, from May 2011 to October 2011.
DESIGN:
Prospective, cross-sectional study.
METHODS AND MATERIALS:
The study involved children with FWS up to 36 months of age. The guideline classifies the risk of serious bacterial infection (SBI) according to the age of the child, the presence or absence of toxemia, clinical presentation, and laboratory screening tests.
RESULTS:
A total of 481 children were included in the present study, but only 385 cases completed the study; 3.9% of patients had toxemia at the initial evaluation. We found 26 children with SBI (6.8%); 12 patients with SBI did not present with toxemia. In all, 40.4% of studied newborns were diagnosed as having a urinary tract infection, and 42.7% of patients as self-limited probable viral etiology. Of the 109 young infants without toxemia, 53.2% were classified as being at high risk of SBI. Of the 163 toddlers without toxemia, 72.4% were treated with antibiotics; 48.4% of patients received therapeutic treatment and 25.8% received empirical treatment.
CONCLUSION:
The guideline followed in our pediatric emergency unit seemed to be appropriate in following up with these children using simple laboratory tests. The most frequent SBI in this sample was urinary tract infection.
AuthorsAhmed Farag Elhassanien, Abdel-Aziz Alghaiaty Hesham, Fawaz Alrefaee
JournalRisk management and healthcare policy (Risk Manag Healthc Policy) Vol. 6 Pg. 7-12 ( 2013) ISSN: 1179-1594 [Print] England
PMID23766664 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: